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ABSTRACT
This study examined the effects of certain characteristics of human immunodeﬁciency virus (HIV)-
infected patients related to the risks of practising unprotected sex (UPS) among 919 HIV-infected
patients who attended the sexually transmitted disease (STD) clinic of the Taipei City STD Control
Center, Taiwan, during the period January–July 2004. After learning that they were HIV-positive, 517
(56%) subjects had practised UPS, 476 (52%) had a new STD diagnosis, and 106 (12%) had used some
form of injected drug. UPS was reported by 76% of homosexual ⁄ bisexual males, 19% of heterosexual
males and 5% of females, and was reported more often by those individuals with casual sexual partners
(p < 0.001). According to multivariate logistic regression analyses, UPS was associated with male-to-
male sexual intercourse (OR 2.46; 95% CI 1.26–4.86, p < 0.001), with casual sexual partners (OR 2.82;
95% CI 1.62–4.88, p < 0.001), and with an individual’s knowledge of his ⁄her HIV status for > 11 years
(OR 2.06; 95% CI 1.02–4.18, p < 0.05). Although using anti-retroviral therapy to prevent sexual
transmission of HIV is rational, the avoidance of at-risk sexual behaviour should also be a priority
among HIV-seropositive individuals. Ongoing risk-reduction counselling related to HIV transmission is
needed to reduce certain sexual behaviours associated with HIV transmission.
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INTRODUCTION
Various anti-retroviral therapies have been avail-
able for more than a decade for the treatment of
human immunodeﬁciency virus (HIV) infection.
The positive impact of highly-active anti-retrovi-
ral therapy (HAART) on morbidity and mortality
caused by HIV has been described previously [1].
HIV viral load is one of the major determinants of
the risk for HIV transmission [2,3]. Widespread
use of HAART could lead to a reduction of HIV
transmission in entire populations and could
effectively contribute to the control of HIV epi-
demics [4,5].
Taiwan has been affected by an HIV epidemic
since 1984, with 6250 HIV cases reported before
July 2004 [6]. In an attempt to counteract the threat
of this HIV epidemic, Taiwan adopted a policy
from April 1997 of providing all HIV-infected
individuals with free access to HAART through
the National Health Insurance scheme [7]. How-
ever, a 16% increase in the prevalence of diag-
nosed HIV infection in Taiwan was noted in 2003
compared with 2002 (from 4769 to 5650 cases) [6].
Although those individuals who are unaware
of their HIV serostatus may be the source of
transmission for many new cases of HIV infec-
tion, HIV-seropositive individuals who are aware
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of their infection status and who engage in high-
risk behaviour may also contribute to HIV trans-
mission within a community [8]. This study
investigated high-risk behaviour with regard to
HIV transmission among HIV-positive patients in
Taiwan.
MATERIALS AND METHODS
Setting
The sexually transmitted disease (STD) clinic of the Taipei City
STD Control Center in Taiwan offers anonymous and free
examination for all STDs. Since 1984, > 2000 of the 6000 HIV-
infected patients in Taiwan have been cared for and provided
with HIV transmission risk-reduction counselling and educa-
tion at this outpatient clinic. The HIV transmission risk-
reduction counselling and education is conducted by the
clinical care team (a clinician, nursing staff, social workers and
a trained health educator). The clinic staff question individuals
concerning their sexual activity and drug use, using a
structured questionnaire, in order to facilitate subsequent
discussions concerning risk reduction.
Study population and deﬁnitions
The present analysis included data concerning patients seen
from January 1997 onwards at the STD clinic of the Taipei city
STD Control Center. Patients were included in the study if
they could provide a documented date for their ﬁrst positive
HIV serological test result, and if they were Taiwanese and
aged ‡ 18 years. Patients were followed-up at 6-month inter-
vals. A new questionnaire was introduced into the follow-up
schedule on 1 January 2004 with questions concerning sexual
behaviour during the preceding 6 months.
Subsequent to requesting and obtaining informed consent
from study participants, a single, conﬁdential, interview,
designed to ascertain HIV transmission risk behaviour, was
conducted in the patient’s native language by an experienced
interviewer who was the trained nurse of the STD clinic. Data
collected from the time subsequent to the patient becoming
aware of his ⁄her HIV-seropositive status included socio-
demographic characteristics (age, gender, education level),
sexual orientation, sexual behaviour (having casual partners,
the number of sexual partners during the individual’s lifetime,
and patterns of condom use), intravenous drug use (IDU), HIV
RNA viral load, history of undergoing anti-retroviral therapy
(ART), and reported diagnosis of STDs. Knowledge of a
partner’s HIV status was not elicited for the period subsequent
to the patient becoming aware of his ⁄her HIV-seropositive
status. Patients who completed a sexual behaviour question-
naire were included in the analysis.
Unprotected sex (UPS) was deﬁned as a patient reporting
that he ⁄ she had not always used condoms during sexual
intercourse (deﬁned as receptive vaginal and ⁄ or anal inter-
course for women; insertive vaginal and ⁄ or anal intercourse
for women; or receptive anal intercourse for men) and ⁄ or the
reported diagnosis of an STD after awareness of his ⁄her
positive HIV test result. Denied unprotected sex (no UPS) was
deﬁned as having no partner, or abstaining from sexual
activity with a partner, or always using condoms during
sexual intercourse and not reporting a diagnosis of any STD
after awareness of his ⁄her positive HIV test result [8].
Patients who reported that they had not always used
condoms during sexual intercourse were then asked to
specify which of seven reasons (difﬁcult to get, embarrassed
to buy, partner does not like them, necessary only with
prostitutes, partner is trusted, condoms are pleasure killers,
and other speciﬁed reason) determined their non-use during
intercourse.
For diagnosis of STDs, the patient was asked whether, at the
time of their ﬁrst positive HIV test result, ‘a doctor, nurse, or
other healthcare provider had ever explained that you had
contracted an STD such as gonorrhoea, syphilis, ulcer lesion on
your genitals from herpes or chancroid, chlamydia, or pelvic
inﬂammatory disease (for women only), or a drip from your
penis (for men)?’ The question regarding diagnosis of an STD
did not distinguish between newly diagnosed and recurrent
STDs, nor was the speciﬁc diagnosis of the STDmade available.
If patients had received any ART at any time since their last
follow-up visit, even if there was an interruption to such
therapy, then they were considered to be receiving ART.
Optimal viral suppression was deﬁned as having plasma HIV
RNA levels £ 400 copies ⁄mL. A viral load > 400 copies ⁄mL
was considered to represent non-optimal viral suppression.
Patients were considered to have optimal viral suppression if
this was the case at all times since their previous follow-up
visit.
Laboratory methods
Conventional analysis of HIV antibodies was performed with a
commercially available enzyme immunoassay (Abbot Labor-
atories, Chicago, IL, USA) and was conﬁrmed by western blot
analyses. HIV-1 RNA was identiﬁed with a nucleic acid
sequence-based ampliﬁcation assay (Organon Teknika,
Durham, NC, USA) used according to the manufacturer’s
instructions. The lower limit of HIV-1 RNA detection was
400 copies ⁄mL serum. All assays were performed by the
Laboratory of Taipei City STD Control Center, Taiwan. A
representative sample of specimens was sent to the Taiwan
Center for Disease Control (CDC, Taiwan) for conﬁrmation of
HIV-1 RNA detection. In both instances, there was good
concordance of results between the primary and reference
laboratories.
Statistical analysis
Statistical analysis was performed using SPSS software v.10.0.5
(SPSS Inc., Chicago, IL, USA). Tests for statistical signiﬁcance
included the 95% CI, two-sided p values based on chi-square
tests or Fisher’s exact test for categorical variables, and
Student’s t-test for continuous variables. Multiple logistic
regression models identiﬁed the risk of UPS subsequent to an
individual’s awareness of a positive HIV test result. In the
multiple logistic regression analysis, UPS subsequent to
knowledge of a positive HIV test result was selected as the
dependent variable, and gender, age, time since notiﬁcation of
a positive HIV test result, male-to-male sexual intercourse, any
use of HAART, and optimal suppression treatment, were set as
independent variables. The common reasons for the non-use of
condoms were assessed among the subset of patients who
reported practising UPS. The reasons for the non-use of
condoms were grouped as situational constraints, better sexual
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sensation, partner relationships, pregnancy-related, or other.
The study was approved by the Institutional Review Board for
the protection of human subjects at the Taipei City STD
Control Center, Taiwan.
RESULTS
Study population
This analysis includes data relating to 919 indi-
viduals infected with HIV-1 who were among
> 1300 HIV-infected patients seen at the STD
Clinic of the Taipei City STD Control Center
during the period January–July 2004. Of these
patients, 95% were men, 79% were unmarried,
and the median age was 36 years (range 21–
65 years). Most (74%) were aged £ 40 years; 67%
(n = 615) reported being homosexual or bisexual;
33% (n = 304) were heterosexual (260 males, 44
females); 56% (517 ⁄ 919) of the patients reported
having practised UPS after they became aware of
their positive HIV test result. In total, 89% of
patients had received ART, of whom 735 (80%)
had a viral load £ 400 copies ⁄mL (Table 1).
Among the study population, the most common
reason for condom use was to prevent the
contraction of an STD (60%) or HIV (20%),
followed by contraception (20%).
STDs
In total, 476 (52%) individuals had an STD
diagnosis before or after awareness of a positive
HIV test result. Diagnosis of an STD after know-
ledge of a positive HIV test result was reported by
219 (24%) patients, of whom 166 (18%) reported
an STD diagnosis both before and after a positive
HIV test result. The most common STD was
genital warts (25%), followed by herpes simplex
virus infection (19%), syphilis (17%) and gonor-
rhoea (10%). Among the patients who reported a
diagnosis of an STD, 83 (32%) of 257 patients who
were diagnosed with syphilis or genital ulcer
disease (GUD) before knowing of their positive
HIV test result were HIV-positive, compared with
eight (15%) of 53 patients who did not have
syphilis or GUD before knowing of their HIV
seropositivity (p < 0.01).
IDU
IDU before knowledge of a positive HIV result
was reported by 106 (12%) of 919 patients, of
whom 82 (78%) reported sharing needles. IDU
after knowledge of a positive HIV test result was
reported by 102 (11%) of 919 patients, of whom 12
(12%) reported sharing needles and ⁄ or other
injection equipment.
Risk-factors associated with UPS
In univariate analysis, UPS following knowledge
of HIV positivity was more likely to be reported
by male individuals who had sex with other men
(OR 2.27; 95% CI 1.70–3.40; p < 0.001), indivi-
duals aged > 30 years (OR 1.37; 95% CI 1.01–
1.85; p < 0.05), those individuals who had been
aware of their positive HIV status for ‡ 11 years
(OR 1.94; 95% CI 1.12–3.41; p < 0.05), and indivi-
duals who reported having casual sexual partners
(OR 2.77; 95% CI 1.58–4.86; p < 0.001). UPS
reported by individuals following knowledge of
HIV positivity was not associated with educa-
tional level, a history of IDU, a history of
Table 1. Demographic characteristics of 919 Taiwanese
subjects participating in a study of risk-factors for unpro-
tected sex after knowledge of their seropositive status for
human immunodeﬁciency virus (HIV)
Variables No. (%) of subjects
Gender
Male 875 (95)
Female 44 (5)
Age in 2004 (years)
21–30 251 (27)
31–40 432 (47)
41–50 148 (16)
> 51 88 (10)
HIV transmission
Men who have sex with men 615 (67)
Heterosexual men 250 (28)
Females 44 (5)
Marital status
Married 163 (18)
Divorced ⁄ separated ⁄widowed 29 (3)
Unmarried 727 (79)
Education level (grade)
£ 6 35 (4)
7–9 74 (8)
10–12 330 (36)
‡ 13 480 (52)
Intravenous drug use
Yes 106 (12)
No 813 (88)
Casual sexual partners
Yes 853 (93)
No 66 (7)
History of anti-retroviral therapy
Yes 816 (89)
No 101 (11)
Optimal viral suppression
Yes (£ 400 copies ⁄mL) 735 (80)
No (‡ 400 copies ⁄mL) 184 (20)
Time since awareness of positive HIV test (years)
£ 1 82 (9)
1–5 493 (54)
6–10 273 (30)
‡ 11 71 (8)
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receiving ART, or documented optimal viral
suppression (Table 2).
In stepwise multiple logistic regression, homo-
sexual activity (OR 2.46; 95% CI 1.26–4.86;
p < 0.001), casual sexual partners (OR 2.82;
95% CI 1.62–4.88; p < 0.001) and knowledge of a
positive HIV test result for ‡ 11 years (OR 2.06;
95% CI 1.02–4.18; p < 0.05) were associated sta-
tistically with UPS, even after an individual
became aware of a positive HIV status (Table 3).
Condom use
Among the 517 patients who reported that they
had participated in UPS, the most common
reasons for non-use of condoms were related to
sexual sensation (44%), partner relationship
(32%) and situational constraints (20%)
(Table 4).
DISCUSSION
In the present study, 56% (517 ⁄ 919) of HIV-
infected study participants reported having UPS.
Men who have sex with men, those with casual
sexual partners, and those who had been aware
of their positive HIV status for ‡ 11 years, were
associated with UPS subsequent to knowledge of
their HIV positivity. The most common reasons
for not using condoms in this study population
were partner relationship (having a trusted part-
ner), pregnancy (using a contraceptive method
other than condoms) and sexual sensation. Con-
sistent with a previous study [9], these results
indicate that men who have sex with men remain
a high-risk group for HIV transmission. In par-
ticular, HIV-positive men who have sex with men
in Taiwan continue to engage in unsafe sexual
practices.
It has been suggested previously that HAART
might increase the frequency of sexual practices
that may lead to the transmission of HIV and
other STDs [10]. It has also been suggested that
homosexual men are now more optimistic about
HIV in the light of new drug therapies, and that
this optimism may have created some degree of
complacency about safer sexual practice, resulting
Table 2. Results of categorical univariate analysis of char-
acteristics associated with unprotected sex (UPS) after
knowledge of human immunodeﬁciency virus (HIV)
seropositivity in Taiwan (total n = 919)
Variables
No. (%) of HIV-
infected individuals
OR (95% CI)aUPS No UPS
Gender
Male 501 (57) 374 (43) 2.34 (1.20–4.61)b
Female 16 (36) 28 (64) 1.00
Age in 2004 (years)
> 30 390 (58) 278 (42) 1.37 (1.01–1.85)c
£ 30 127 (51) 124 (49) 1.00
HIV at-risk behaviour
MSM 387 (63) 228 (37) 2.27 (1.70–3.40)b
No MSM 130 (43) 174 (57) 1.00
Marital status
Married 83 (51) 80 (49) 0.77 (0.54–1.10)
Divorced ⁄ separated ⁄widowed 17 (59) 12 (41) 1.05 (0.47–2.38)
Unmarried 417 (57) 310 (43) 1.00
Education level (grade)
< 13 252 (57) 187 (43) 1.09 (0.83–1.43)
‡ 13 265 (55) 215 (45) 1.00
Intravenous drug use
Yes 67 (63) 39 (37) 1.39 (0.89–2.15)
No 450 (55) 363 (45) 1.00
Casual sexual partners
Yes 495 (58) 358 (42) 2.77 (1.58–4.86)c
No 22 (33) 44 (67) 1.00
History of ART
Yes 467 (57) 349 (43) 1.35 (0.88–2.08)
No 50 (50) 51 (50) 1.00
Optimal viral suppression
Yes (£ 400 copies ⁄mL) 411 (56) 324 (44) 0.95 (0.72–1.25)
No (> 400 copies ⁄mL) 106 (58) 78 (42) 1.00
Time since knowledge of
positive HIV test (years)
‡ 11 50 (70) 21 (30) 1.94 (1.12–3.41)c
< 11 467 (55) 381 (45) 1.00
MSM, men who have sex with men; ART, anti-retroviral therapy.
aComparing UPS to no-UPS; chi-square test for categorical variables and t-test for
continuous variables.
bp < 0.001.
cp <0.05.
Table 3. Risk-factors for unprotected sex (UPS) by mul-
tiple logistic regression analysis
Variables OR 95% CI
MSM (yes ⁄no) 2.46 1.26–4.86a
Having casual sexual partners (yes ⁄ no) 2.82 1.62–4.88a
Knowing positive HIV test for
‡ 11 years (yes ⁄no)
2.06 1.02–4.18b
MSM, men who have sex with men.
Dependent variable was UPS ⁄non-UPS; independent variables available to the
model were age (years), gender (male ⁄ female), male-to-male sex (yes ⁄no), casual
partners (yes ⁄no), knowledge of a positive human immunodeﬁciency virus (HIV)
test for ‡ 11 years (yes ⁄no), anti-retroviral therapy (yes ⁄no), and optimal
suppression treatment (yes ⁄no). Only results of signiﬁcant variables are presented.
ap < 0.001.
bp < 0.05.
Table 4. Reasons for not using condoms, Taiwan, 2004
Reason No. (%)
Situational constraints
Difﬁcult to get 103 (20)
Sexual sensation
Partner does not like them 41 (8)
Pleasure killers 186 (36)
Partner relationships
Partner is trusted 83 (16)
Necessary only with prostitutes 83 (16)
Other reasons
Other reasons (don’t know, don’t think about it) 20 (4)
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in an increase in high-risk sexual behaviour [11].
The present study reports similar ﬁndings, in that
the likelihood of practising UPS following the
notiﬁcation of an individual’s positive HIV test
result did not appear to differ between those who
received HAART and those who did not (57% vs.
50%; p > 0.05).
The prevalence of at-risk sexual behaviour with
regard to HIV transmission was higher among
patients who were aware of their positive HIV test
result for a longer, rather than a shorter, period.
This may be the result of a cumulative effect
related to increased opportunity for at-risk sexual
behaviour and ⁄ or a waning of an individual’s
motivation for risk-behaviour modiﬁcation (pre-
vention fatigue) that leads to a return to unsafe
sexual practices [12]. Such a progressive beha-
vioural change might be associated with a
reduced perception among homosexual men of
the need for safe sexual practices subsequent to
the availability of HAART [13,14]. Thus, intensive
educational efforts to modify behaviour and
promote condom use should be included in
possible prevention strategies.
As in previous cross-sectional studies, there
does not appear to be evidence to support the
hypothesis that HIV-infected individuals under-
going ART, and those with optimal viral sup-
pression, are more likely to engage in unsafe
sexual behaviour [15]. Indeed, the current analy-
sis found that individuals receiving ART were not
associated with UPS. This ﬁnding adds to the
growing debate regarding the role of ART in an
individual’s perception of HIV infectiveness and
what actually constitutes at-risk sexual behaviour
[16].
There is now clear epidemiological evidence
that sexually transmitted infections increase HIV
viral shedding in the genital tract, and they have
been associated with an increased risk of HIV
transmission, even in the case of patients receiv-
ing ART [17]. The present study also indicates
that patients who reported pre-existing syphilis or
GUD were at higher risk for acquiring HIV than
patients who did not (p < 0.01), which empha-
sises the importance of controlling syphilis and
GUD in the prevention of HIV.
Previous studies of IDU have demonstrated an
increased risk of HIV infection among individuals
who report sharing needles regularly [18]. It was
encouraging that reports of IDU and needle
sharing were much less frequent once individuals
became aware of their positive HIV status. How-
ever, once HIV is introduced into a community, it
spreads rapidly among most intravenous drug
users [19]. Risk-reduction counselling by health-
care providers is needed to control HIV infection
in this group.
The present study had several limitations. First,
sexual behaviour in this study was entirely
self-reported during an interview with an indi-
vidual’s nurse, which may represent an under-
estimate of actual risk behaviour [20]. Second, the
accuracy of recall of at-risk behaviour may be
affected by the delay since the patient ﬁrst became
aware of his/her HIV-seropositive status. Third,
asymptomatic or mild STDs might not prompt a
patient to visit an STD centre; however, the
potential for reporting bias was assessed by
utilising two deﬁnitions of reported UPS. Clearly,
a prospective study is needed to address these
important issues in more depth. Fourth, this
study could not examine the exact temporal
relationship between knowledge of HIV serosta-
tus and at-risk behaviour because of the cross-
sectional design.
The present ﬁndings demonstrate that individ-
uals who know that they are HIV-positive may
still be an important source for the possible
transmission of HIV and STDs in Taipei. Safe-
sex promotion is important to maintain HIV ⁄ STD
infection at the lowest possible level, as is a
continuous education programme to promote
condom use during sexual intercourse for perso-
nal protection and to introduce behavioural
modiﬁcation in order to reinforce safe-sex prac-
tices.
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